Two Ipilimumab Trials Show Survival Benefit, and More Toxicity

Dr Weber discusses two studies that show a clear survival advantage with ipilimumab, but at a significant price in toxicity.

Source: Medscape Oncology - October 31, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts